Filing Details
- Accession Number:
- 0001140361-10-021822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-17 13:00:00
- Reporting Period:
- 2010-05-13
- Filing Date:
- 2010-05-17
- Accepted Time:
- 2010-05-17 17:44:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1137861 | Wright Medical Group Inc | WMGI | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 134088127 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213472 | D Gary Henley | 5677 Airline Road Arlington TN 38002 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-13 | 62,466 | $0.00 | 156,567 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2010-05-14 | 4,950 | $17.52 | 151,617 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2010-05-13 | 48,479 | $0.00 | 48,479 | $18.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,479 | 2020-05-13 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | By Henley Family Limited Partnership |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on the date of grant of restricted stock for the purpose of selling shares as necessary to satisfy applicable withholding obligations upon vesting of restricted stock.
- The reported price is the weighted-average sale price per share for transactions at seven price points in which the purchase prices ranged from $17.50 to $17.56 per share. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price point upon request of the Securities and Exchange Commission staff, issuer, or a stockholder of issuer.
- The stock option vests and becomes exercisable in four equal annual installments beginning on 05/13/2011.
Billionaire Hedge Funds
